Apyx Medical (APYX) Current Assets (2010 - 2026)

Apyx Medical's Current Assets history runs 17 years deep, the most recent figure standing at $54.8 million for Q1 2026.

• Quarterly Current Assets rose 5.68% year-over-year to $54.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.8 million (up 5.68% YoY) and the FY2025 annual result came in at $58.5 million, up 3.6% from the prior year.
• Current Assets was $54.8 million for Q1 2026 at Apyx Medical, down from $58.5 million in the prior quarter.
• Across five years, Current Assets topped out at $70.4 million in Q4 2023 and bottomed at $43.0 million in Q4 2022.
• A 5-year average of $53.6 million and a median of $52.7 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets decreased 29.25% — and 2023, when it surged 63.74%.
• Apyx Medical's Current Assets stood at $43.0 million in 2022, then jumped by 63.74% to $70.4 million in 2023, then retreated by 19.79% to $56.4 million in 2024, then gained by 3.6% to $58.5 million in 2025, then dropped by 6.29% to $54.8 million in 2026.
• Business Quant data shows APYX's Current Assets at $54.8 million in Q1 2026, $58.5 million in Q4 2025, and $48.8 million in Q3 2025.